InMed Pharmaceuticals (INM) Other Working Capital Changes (2021 - 2025)
Historic Other Working Capital Changes for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $467042.0.
- InMed Pharmaceuticals' Other Working Capital Changes rose 27380.41% to $467042.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $111094.0, marking a year-over-year increase of 10913.38%. This contributed to the annual value of -$429880.0 for FY2025, which is 816.71% down from last year.
- Per InMed Pharmaceuticals' latest filing, its Other Working Capital Changes stood at $467042.0 for Q4 2025, which was up 27380.41% from -$129992.0 recorded in Q3 2025.
- InMed Pharmaceuticals' Other Working Capital Changes' 5-year high stood at $1.2 million during Q1 2022, with a 5-year trough of -$918075.0 in Q2 2024.
- Its 5-year average for Other Working Capital Changes is -$61527.1, with a median of -$122325.5 in 2025.
- As far as peak fluctuations go, InMed Pharmaceuticals' Other Working Capital Changes soared by 32081.95% in 2022, and later tumbled by 74161.43% in 2024.
- InMed Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$212964.0 in 2021, then skyrocketed by 320.82% to $470266.0 in 2022, then soared by 90.95% to $897962.0 in 2023, then tumbled by 86.09% to $124943.0 in 2024, then soared by 273.8% to $467042.0 in 2025.
- Its Other Working Capital Changes was $467042.0 in Q4 2025, compared to -$129992.0 in Q3 2025 and -$114659.0 in Q2 2025.